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Abstract 
 
 miRNAs are abundant regulatory RNAs involved in the regulation of many 
key biological processes. Recent advances in understanding the mechanism of RNAi 
and miRNA-mediated mechanisms shed light on major principals of the formation of 
the regulatory complex and provide models to explain how these small regulatory 
RNA species interfere with gene expression and how they influence the translational 
status of the transcriptome.  
 
Introduction 
 
 Pathways that function on the basis of the principles of RNA interference 
(RNAi) are highly conserved mechanisms of gene regulation. Archean and eukaryotes 
harbour several key components of the RNAi machinery and the function of RNAi 
related mechanisms has been studied in diverse eukaryotic model systems (Cerutti & 
Casas-Mollano, 2006). RNAi, apart from providing an indispensable reverse genetic 
tool (Elbashir et al., 2001) and promising therapeutic approach (Zimmermann et al., 
2006), is key regulator of gene expression on both transcriptional and post-
transcriptional level and it is involved in the defence against viruses and bacteria. 
RNAi provides switch points in many developmental processes and it is a key 
determinant in regulating mechanisms leading to diseases including cancer 
(Wienholds & Plasterk, 2005). 
 The hallmark of all RNA silencing mechanisms is the transformation of the 
sequence information of some species of long RNAs with double stranded (dsRNA) 
characteristic into small 20-27 nucleotide (nt) long regulatory RNAs, which serve as 
the specific determinants of a protein complex, the RNA Induced Silencing 
Complexes (RISC), that represses gene expression. Among the small regulatory 
RNAs associated with diverse RNAi based mechanisms microRNAs (miRNA) are 
probably one of the most abundant ones in plants and metazoan. For instance, 
miRNAs are predicted to constitute ~ 3% of human genes and they may contribute to 
the post-transcriptional regulation of at least one third of the human mRNAs. 
 Here, we review the principles and mechanisms of miRNA-mediated gene 
regulation taking the assembly of a functional RISC as our starting point.  
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RISC formation 
 
 The machinery of RNAi achieves specificity in transcriptional silencing, 
targeted RNA cleavage and translational repression through its RNA-programmed 
protein complexes. RISC was first defined as a large RNA-protein complex with 
sequence-specific RNA cleavage activity that could be purified by chromatographic 
fractionation from cells programmed in vivo or in vitro with longer dsRNA or siRNA 
(Hammond et al., 2000; Zamore et al., 2000). Biochemical approaches and genetic 
screens in protists, plants, fungi and C. elegans have unambiguously identified the 
members of the Argonaute protein family as essential protein components of both the 
cleavage-competent RISCs and the miRNA-containing RNPs (miRNP) (Baumberger 
& Baulcombe, 2005; Hammond et al., 2001; Liu et al., 2004; Meister et al., 2004; 
Mourelatos et al., 2002; Qi et al., 2005). Argonaute orthologues have been identified 
in bacteria, archea and most but not all eukaryotes (Cerutti & Casas-Mollano, 2006). 
 Argonautes have the four following characteristic conserved protein domains: 
N terminal, Mid, PAZ and PIWI domain. The three-dimensional structures of 
bacterial and archaeal Argonaute proteins and the PAZ domains of eukaryotic 
Argonautes revealed that the PAZ domain binds the short single-stranded 3´ ”tails” 
characteristic of an siRNA. It has been postulated that the PAZ domain initiates 
incorporation of a small RNA into RISC by binding the single-stranded 2nt 
3´overhang of an siRNA or miRNA duplexes (Lingel et al., 2003; Ma et al., 2005; 
Song et al., 2003; Song et al., 2004; Yan et al., 2003). More remarkably, these 
structural studies revealed that the key to understanding the sequence-specific activity 
of RISC resides in the structure of the PIWI domain, whose three-dimensional fold 
clearly places in the RNase H enzyme family of nucleic-acid directed RNA-
endonucleases (Ma et al., 2005; Parker et al., 2005; Song et al., 2004; Yuan et al., 
2005). This finding is consistent with earlier biochemical studies showing that 
chemistry of cleavage by human and fly RISC has many similarities to RNAse H-
mediated catalysis: a requirement for the divalent cation Mg 
2+ 
and cleavage products 
with 5´terminal phosphates and 3´terminal hydroxyl groups (Martinez & Tuschl, 
2004; Schwarz et al., 2004). A minimal and active human RISC reconstituted in vitro 
from single-stranded siRNA and recombinant human Ago2 (hAgo2) shows similar 
chemical and kinetic properties to the larger fly and human cleavage-competent 
RISCs formed in unpurified cell extract (Haley & Zamore, 2004; Martinez & Tuschl, 
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2004; Rivas et al., 2005). Moreover, tethering hAgo1-hAgo4 to the 3´UTR of an 
mRNA through a sequence-specific protein RNA-binding domain rather than by a 
small RNA showed that Argonaute proteins themselves can initiate the repression of 
mRNA translation (Pillai et al., 2004).  
 The complexes that form around the minimal RISCs appear to be very diverse. 
Their sizes, from ~ 160 kD (minimal RISC) to 80S (“holo-RISC”), and protein 
components differ from report to report, depending on the model system and 
purification approaches (Hammond et al., 2001; Martinez et al., 2002; Pham et al., 
2004; Zamore et al., 2000). For instance, D.melanogaster RISC complexes have been 
shown to contain, in addition to an Argonaute, Fragile X mental retardation 1 protein 
(dFMR), Vasa intronic gene (VIG) and Tudor staphylococcal nuclease (TSN) (Caudy 
et al., 2002; Ishizuka et al., 2002). The functions of these co-purified factors are 
largely unknown yet. In human cells Gemin 3 and 4 have been identified in complex 
together with hAgo2 (Meister et al., 2005a; Mourelatos et al., 2002). Both hAgo1 and 
hAgo2 co-purify with the helicase Mov10, the fly orthologue of which is required for 
RISC assembly, Tncr6 Bisoform1 and Prmt5 proteins with unknown function 
(Meister et al., 2005b; Tomari et al., 2004a).  
 There is an increasing number of reports that Argonautes associates with 
complexes that contain Dicer, the key enzyme in siRNA and miRNA maturation 
(Duchaine et al., 2006; Gregory et al., 2005; Maniataki & Mourelatos, 2005; Meister 
et al., 2005b; Okamura et al., 2004; Sasaki et al., 2003; Tabara et al., 2002). The co-
association of RISC and the miRNA processing is not surprising. Dicer not only 
generates short-lived double-stranded siRNA and miRNA intermediates but also 
participates in the downstream process that lead to the selection of one of the strands, 
the guide strand of an siRNA, and participates in its incorporation into an Argonaute. 
The combination of genetic and biochemical approaches in fly identified the RISC 
loading complex (RLC) that activates and transfers one strand of an siRNA onto the 
fly Ago2 (Lee et al., 2004; Liu et al., 2003; Pham et al., 2004; Tomari et al., 2004b). 
RLC contains at least Dicer-2, one of the two fly Dicers that predominantly process 
long dsRNAs and bind to siRNAs, and its dsRNA-binding interactor R2D2 (Tomari et 
al., 2004b). The key determinant in strand selection and unwinding is the 
thermodynamic difference between the two 5´ends of an siRNA (Khvorova et al., 
2003; Schwarz et al., 2003). R2D2 recognizes and binds to the relatively more stable 
5´end of the siRNA positioning Dicer-2 onto the 5´end of the guide strand, whose 
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5´end is less tightly paired than the corresponding 5´end of the passenger strand, and 
facilitates its incorporation into RISC. Both R2D2 and Dicer-2 are necessary but not 
sufficient to complete the unwinding of the duplex suggesting that other factors are 
required for this process. Indeed, one such factor is very likely to be the Argonautes 
themselves. In spite of the fact, that the recombinant hAgo2 are not capable of 
unwinding short RNA duplexes, genetic data in flies suggest that Ago2 is 
indispensable for this process (Okamura et al., 2004). In fact, it has been recently 
demonstrated that the cleavage competent fly and the human Ago2 actively 
participate in the unwinding mechanism by cleaving the passenger strand of the 
perfectly double-stranded siRNA (Leuschner et al., 2006; Matranga et al., 2005; 
Miyoshi et al., 2005).  
 The pathway has been most thoroughly studied for RISC assembly initiated by 
long dsRNA or siRNAs, but it is likely that similar RISC loading mechanisms operate 
when RISC is charged with miRNAs. The majority of miRNAs are represented with 
one strand of the stem of the pre-miRNA, predominantly with the strand that has 
thermodynamically weaker 5´ end, at steady state level suggesting that miRNA 
maturation follows the rule of the asymmetric RISC formation. In addition, 
orthologues of R2D2 are important for RNAi and miRNA processing in worms flies 
and mammals. The miRNA specific fly Dicer-1 requires Loquacious, for proper 
miRNA processing, Dicer in worms co-immunoprecipitates with RDE-4, a dsRNA-
binding protein essential for RNAi initiated with long dsRNA, and human Dicer 
requires two R2D2 othologues, TRBP and PACT, for miRNA-mediated gene 
silencing (Chendrimada et al., 2005; Forstemann et al., 2005; Haase et al., 2005; Jiang 
et al., 2005; Lee et al., 2006; Saito et al., 2005; Tabara et al., 2002). Furthermore, 
Argonautes seem to interact physically with the miRNA maturation and loading 
machinery since immunoprecipitated hAgo2 complexes contain functional Dicer 
activity that can asymmetrically process exogenous pre-miRNAs, generating mature 
RISC that can cleave a perfect complementary target RNA (Gregory et al., 2005; 
Maniataki & Mourelatos, 2005; Meister et al., 2005b). Together, the data suggest that 
RISC formation is a highly dynamic process that requires the coordinated interaction 
of complexes involved in distinct steps of siRNA and miRNA maturation (Fig.1.). 
 
Mechanism(s) of miRNA-mediated gene regulation 
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 According to our current understanding, miRNA-guided posttranscriptional 
gene-regulation follows at least two distinct mechanisms based on the characteristics 
of the target recognition by miRNAs. First, the target can be cleaved at a fixed 
position relative to the miRNA complementary sequence (Hutvagner & Zamore, 
2002) . Second, the translation of the target RNA may be inhibited, without initiating 
sequence-specific mRNA degradation.  
 There are two basic requirements for miRNA-mediated sequence-specific 
cleavage. The Argonaute in RISC has to bear catalytic activity, and the 
complementary between the miRNA and target has to have sufficient to initiate 
sequence-specific cleavage. Although all Argonaute proteins contain a PIWI domain 
with its characteristic RNAse H fold not all have retain catalytically active aspartate-
aspartates-histidine (DDH motif) (Liu et al., 2004; Meister et al., 2004). However, the 
loss of DDH motif is not sufficient to explain the loss of catalytic activity for some 
Argonaute proteins. For example, human Ago3 contains an intact DDH motif but the 
protein cannot initiate sequence-specific cleavage. Alternatively, hAgo3 catalized 
target cleavage may require additional cofactors not yet identified or be restricted to a 
subset of targets or small RNA guides not yet explored (Liu et al., 2004; Song et al., 
2004). In flies, both Ago1, which prefers to bind miRNAs and Ago2 that binds 
siRNAs, can show catalytic activity if a sufficiently complementary target is 
presented (Okamura et al., 2004). In spite of the fact, that all exogenously introduced 
human Argonautes equally bind to siRNAs and miRNAs only hAgo2 is capable of 
targeted RNA cleavage (Liu et al., 2004; Meister et al., 2004).  
 The outcomes of in vivo approaches, structural studies of PIWI and Argonaute 
proteins, and kinetic analysis of purified or “holo-RISCs” revisited the early view 
about the degree of specificity of the sequence-specific RNA cleavage. Now, it is 
clear that target cleavage requires a continuous A-form helix between the small 
regulatory and the targeted RNAs (Chiu & Rana, 2003; Haley & Zamore, 2004). The 
helix spans from the second to the 12
th
 nucleotide of an siRNA or miRNA, counted 
from its 5´end, that result in a cleavage between the 10
th
 and 11
th
 nucleotides as a 
consequence of placing the scissile phosphate near the active site of the Argonautes 
(Haley & Zamore, 2004; Ma et al., 2005; Parker et al., 2005; Song et al., 2004). The 
miRNA mediated cleavage of transcripts results in the production of 5’ and 3’ 
fragments characteristic to RNAse H activity (Martinez & Tuschl, 2004; Schwarz et 
al., 2004), which are subsequently processed by different degradation pathways. In 
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Drosophila cells, the elimination of the 3’ fragments is mediated by Xrn1, and it is 
not dependent on the exosome components Rrp4 or Ski2. On the other hand, the 5 
fragment is likely to be degraded by the exosome. Although both deadenylation and 
decapping of transcripts seems to facilitate mRNA degradation, neither of the two 
steps appears to take place before processing of the 3’ or 5’ fragments by Xrn1 or 
Ski2 (Orban & Izaurralde, 2005).  
 In contrast to plants in humans only a few examples are known when a 
miRNA-target pair exhibits sufficient complementary to initiate sequence-specific 
target degradation. The interaction between miR-196, and its target RNA, HOXB8, 
can be traced in mouse embryos by following the characteristic RNA fragments 
deriving from the sequence-specifically cleaved HOXB8 transcript (Hornstein et al., 
2005; Yekta et al., 2004). The imprinted PEG-11/rtl1 gene gives rise to an intronless 
transcript from its paternal copy, which is maternally repressed. From this locus 
however, a maternal antisense transcript arises that contains a number of hairpin-loop 
structures that are processed into miRNAs that have been shown to repress the 
paternal sense transcript. These miRNAs are necessarily perfectly complementary to 
their target, which is subsequently cleaved in a sequence specific manner (Davis et 
al., 2005; Seitz et al., 2003). The estimated number of human genes that are possibly 
targets of miRNA guided sequence-specific cleavage rather than translational 
repression, is about 40. Among these are MCL-1, LIMK-1 and MUSASHI-1, likely 
targeted by miR-298, miR-328 and miR-129 respectively, which encode proteins with 
anti-apoptotic functions (John et al., 2004). 
 The majority of animal miRNAs have only limited complementary to their 
experimentally verified or predicted targets and the level of base pairing between 
most of the miRNAs and their targeted sequences prevent miRNAs from inducing 
sequence-specific cleavage. The miRNA-target RNA interaction appears restricted to 
the 5´end of the miRNA sequence that was shown to contribute the most to the target 
binding (Doench & Sharp, 2004; Haley & Zamore, 2004; Lewis et al., 2003; 
Rajewsky & Socci, 2004). In fact, it is well established that the perfect 
complementary between the miRNA 2-8 nucleotides, so called “seed sequence”, and 
the targeted RNA is absolutely essential for target recognition. In this region, a single 
mismatch blocks binding, although a shorter seed pairing may be compensated by 
extensive matching between the target and the 3´ regions of the miRNAs (Brennecke 
et al., 2005; Kloosterman et al., 2004; Lai et al., 2005; Lewis et al., 2003). Another 
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function of the 3´region of a miRNA is to give specificity to the members of miRNA 
families that share identical seeds but they diverge in their 3´sequences (Brennecke et 
al., 2005). The recognition of the principles of miRNA targeting accelerated the 
development and improvement of a series of bio-computational approaches to predict 
miRNA targets in animals that produced a remarkably large number of putative 
miRNA regulated transcripts further emphasizing the significance of miRNAs 
(Enright et al., 2003; Kiriakidou et al., 2004; Lall et al., 2006; Lewis et al., 2005; 
Stark et al., 2003). 
 In spite of the fact that miRNAs bind their targets by following an almost 
universal mechanism, the only exception so far is miR-16 that was suggested to base-
pair with its target by initiating a non-canonical conformation (Jing et al., 2005), it 
seems that at the level of gene regulation the outcome of these interactions can be 
diverse. The worm lin-4, the founding member of miRNAs, together with its target 
RNAs associate with polyribosomes but no protein is made suggesting that the lin-4 
miRNA inhibits translation after the initiation step, most likely slowing down the rate 
of polypeptide elongation or stability (Olsen & Ambros, 1999; Seggerson et al., 
2002). In fact, many miRNAs have been associated with polysomes, in cultured 
human cells (Nelson et al., 2004) and primary cortical neurons (Kim et al., 2004). 
Recently, the most detailed analysis of the miRNA-mediated inhibition of 
translational elongation was carried out in human cells. siRNAs, mimicking miRNA 
action by imperfectly matching them to the 3´UTR of a reporter, silenced the 
translation of the target after initiation, concluded from the data that showed efficient 
regulation of a construct with IRES, by increasing translation termination that 
eventually resulted in ribosome drop off (Petersen et al., 2006). However, miRNAs 
also interfere with translation at the initiation step. Analysing of the effects of both 
exogenously provided miRNA-like siRNAs or endogenous miRNAs on the 
translation of their reporter and endogenous targets in human cells showed that the 
5´cap is required for miRNA-mediated translational repression, because IRES 
initiated translation or tethering eIF4E and eIF4G to the reporter was immune to 
miRNAs (Humphreys et al., 2005; Pillai et al., 2005). The two reports disagree with 
the prerequisite of the poly(A) tail for the inhibition, but in cell free translation system 
both the 5´ cap and the poly(A) tail has been shown to be required for recapitulating 
miRNA-mediated translational repression (Wang et al., 2006). These results argue 
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that miRNA programmed RISCs can prevent the recruitment of translation factors to 
the 5´cap of the mRNA.  
 Regulation by miRNAs also appears to be connected to the Processing body 
(P-bodies, GW-bodies, PBs), a cytoplasmatic structure involved in storage and 5´ to 
3´destruction of mRNA. In cultured human cell miRNA-binding caused the targeted 
mRNA to localize to P-bodies, which is argued to occurs in response to the primary 
regulatory event, repression of translational initiation (Bhattacharyya et al., 2006; 
Pillai et al., 2005). Indeed, eIF4e and eIF4e-transporter proteins participate in the 
transport of mRNAs into the PBs (Andrei et al., 2005) and in yeast inhibition of 
translation initiation increases localization of an mRNA to PBs (Sheth & Parker, 
2003).  
 Human Argonaute proteins and C. elegans ALG-1, a worm Argonaute protein 
required for let-7 directed gene regulation, co-localize, co-purify and interact with 
proteins also located in PBs (Ding et al., 2005; Jakymiw et al., 2005; Liu et al., 2005a; 
Liu et al., 2005b; Meister et al., 2005b; Sen & Blau, 2005). The localization of 
Argonaute proteins to PBs requires that the protein bind small RNAs; the target 
mRNA is transported to the PB only if it contains miRNA binding sites, suggesting 
that miRNAs bound to Argonaute proteins direct the mRNA to the (Agbottah et al., 
2005; Liu et al., 2005a; Liu et al., 2005b; Pillai et al., 2005). Three lines of evidence 
support the idea that the existence of complexes associated with Argonaute proteins in 
the PBs is not only a consequence of inhibiting the translation of miRNA-regulated 
transcripts but PB localized RISCs might have an autonomous role in miRNA 
mediated repression. First, exogenously transfected siRNAs with no known 
endogenous mRNA targets localized to PBs (Jakymiw et al., 2005). Second, depletion 
by RNAi of PB components, such as GW182 protein, decapping enzymes (Dcp1a, 
Dcp2), RCK/p54 and the 5´-to- 3´exonuclease Xrn1, impair both RNAi and miRNA-
mediated repression in flies worm and cultured human cells (Chu, 2006; Ding et al., 
2005; Jakymiw et al., 2005; Liu et al., 2005a; Rehwinkel et al., 2005). Finally, 
Mov10, the human homolog of Armitage, a helicase required in flies for RISC 
assembly in the germ line, interacts with human Ago1 and Ago2 and is localized in 
the PBs. Moreover, AIN-1, the worm GW182 ortholog, interacts with DCR-1 
suggesting that events before RISC assembly may take place in these structures (Ding 
et al., 2005; Meister et al., 2005b). The RNA and miRNA independent interaction 
between hAgo2 and Dcp1a strengthens this hypothesis (Liu et al., 2005b).  
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 What is the fate of the miRNA-targeted mRNAs after their transfer to PBs? 
PBs contain the RNA decay machinery, suggesting they degrade the miRNA-targeted 
mRNAs. In fact, miRNA-binding can clearly destabilize target mRNA by a 
mechanism distinct from the Argonaute-catalyzed sequence specific cleavage that 
characterize RNAi (Bagga et al., 2005; Farh et al., 2005; Giraldez et al., 2006; Lim et 
al., 2005). Detailed analyses of miRNA-directed mRNA decay revealed that miRNAs 
induce translation-independent deadenylation of the targeted mRNA, which is the 
hallmark of deadenylation-dependent decapping followed by 5´-to-3´ decay (Giraldez 
et al., 2006; Wu et al., 2006). Remarkably, AU-rich elements (ARE) in the 3´UTRs of 
unstable mRNAs can also accelerate the shortening of the poly(A) tail triggering 
decapping and RNA destruction, and there are hints of connections between the 
miRNA and ARE pathways. For instance, miR-16 may recruit TTP to canonical 
AREs through the members of the Argonaute family. Interestingly, TTP forms a 
complex with hDcp1a, hDcp2 and hXrn1, and overexpressed TTP co-localizes with 
PBs (Jing et al., 2005; Kedersha et al., 2005; Lykke-Andersen & Wagner, 2005). 
Moreover, the ARE binding protein HuR involved in reversing the miR-122 mediated 
repression of the CAT-1 mRNA (Bhattacharyya et al., 2006). However, mRNAs do 
not always respond with significantly decreased stability when targeted by miRNAs. 
(Bhattacharyya et al., 2006; Humphreys et al., 2005; Petersen et al., 2006; Pillai et al., 
2005; Wang et al., 2006). And miRNA targeted, translationally repressed transcripts 
can be transported to PBs without destruction suggesting that PB may function as a 
reservoir where quiescent mRNAs stored, possibly allowing their reuse for translation 
(Bhattacharyya et al., 2006; Pillai et al., 2005).  
 A new model proposes to integrate the disparate models for miRNA-mediated 
mechanisms. The model postulates that the inherent stability and turnover rate of a 
mRNA determines if miRNA-binding manifests in repression of translation (without 
mRNA destabilization) or in accelerated degradation of the mRNA (causing a 
decrease in its steady-state abundance) (Valencia-Sanchez et al., 2006). However, it 
remains possible that miRNAs sequester and/or degrade their mRNA targets by 
divergent but interrelated mechanisms. For example, different neuronal miRNAs 
show distinct polysomal distributions patterns in the same cells (Kim et al., 2004). 
The choice among pathways may be regulated by developmental and environmental 
cues or may reflect the different stoichiometries between different miRNAs and their 
targets.  
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Global effects of miRNAs on gene expression 
 
 The first miRNAs were identified as key regulators of developmental timing 
in C. elegans suggesting that miRNAs, in general, may play decisive regulatory roles 
in transitions between different developmental programmes by switching off a few 
targets (Lee et al., 1993; Reinhart et al., 2000). Indeed, the results of genetic screens 
in worm and fly supported this view by presenting additional miRNAs with bold 
phenotype in developmental processes (Brennecke et al., 2003; Johnston & Hobert, 
2003). The targeted mRNAs that are involved in this “switch target” (Bartel & Chen, 
2004) type regulation bear multiple miRNA-binding sites in their 3´UTRs that 
facilitate the radical inhibition of translation of abundant messages via the cooperative 
actions of miRNAs (Doench & Sharp, 2004). However, current experimental and 
bioinformatics data argue that the developmental switch function of miRNAs may be 
exceptional and the role of miRNAs in gene regulation is much more complex. For 
example, one miRNA can regulate hundreds of targets simultaneously (Giraldez et al., 
2006; Lim et al., 2005) and target predictions unambiguously suggest that mRNAs 
with multiple miRNA binding sites are very rare, about 2% of the predicted targets 
have more than one predicted miRNA-binding sites. The majority of the putative 
targets have only a single miRNA-binding site for individual miRNAs which 
probably is non sufficient for governing switch type regulation. Furthermore, 
inhibitions of all miRNAs by depleting Dicer do not severely impair differentiation 
and patterning in vertebrates (Giraldez et al., 2005; Harfe et al., 2005). Indeed, 
miRNAs have recently been hypothesized to be part of genetic networks wired by 
feed-forward loops (FFL) that maintain the fidelity of developmental programs, rather 
than initiating developmental transitions, by conferring robustness with both 
preventing leaky transcriptions and buffering genetic noise (Hornstein & Shomron, 
2006). The robustness provided by miRNAs was experimentally confirmed in flies by 
examining the expression patterns of abundant, developmentally regulated miRNAs 
and their conserved targets. In these cases miRNAs and targets with conserved 
bonding sites have “mutually exclusive” expression patterns meaning that miRNAs 
and their targets are highly expressing in spatially and temporarily neighbouring 
tissues but they are generally excluded from the same tissues suggesting that miRNAs 
prevent misexpression of non-wanted, leaky, transcripts (Stark et al., 2005). In 
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addition, abundant messages that co-express with miRNAs evolved to avoid miRNA-
mediated repression by shortening their 3´UTR and selecting against sequences 
complementary to seed sequences of miRNAs (Farh et al., 2005; Stark et al., 2005). 
 In summary, miRNAs are not only involved in directly regulating up to one 
third of the metazoan transcriptomes but they are a driving force behind the evolution 
of 3´UTR which may easily affect virtually all existing transcripts. 
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Figure legend 
 
 RISC formation (1-4) is a dynamic process. The pre-miRNA is cleaved (1) 
and one strand of an siRNA or a miRNA is selected and loaded by the RLC (2-3) into 
RISC (4).  
 miRNAs can be engaged in diverse but interrelated regulatory mechanisms (5-
11). Should miRNAs share sufficient complementary with their targets and are 
incorporated into a cleavage competent Argonaute then miRNAs may initiate 
endonucleolytic cleave of the mRNA (5). The cleaved mRNA is further degraded by 
the exosome and by Xrn1 (11). miRNAs can inhibit translation after translation 
initiation resulting in ribosome drop off (6) or they impede translation initiation (7). 
mRNAs targeted by RISC and excluded from translating ribosomes are transported to 
P-bodies (8) where they are stored or degraded (9). RISC can also be localized in P-
bodies on a target independent manner and P-body components are required for RISC 
activity or RISC assembly (10). 
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